ArticleJournal of Korean medical science2022

Effectiveness and Safety of Regdanvimab in Patients With Mild-To-Moderate COVID-19: A Retrospective Cohort Study.

Susin Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.